AI assistant
Sending…
Climb Bio, Inc. — Director's Dealing 2025
Apr 1, 2025
33982_dirs_2025-04-01_f3d6f826-f6fc-40d6-a558-a83ec51721ac.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Climb Bio, Inc. (CLYM)
CIK: 0001768446
Period of Report: 2025-03-28
Reporting Person: Cumbo Alexander (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-03-28 | Stock Option (Right to Buy) | $1.28 | A | 80000 | Acquired | 2035-03-27 | Common Stock (80000) | Direct |
Footnotes
F1: The shares underlying the option vest in equal monthly installments from March 28, 2025 (the "Vesting Commencement Date") until the third anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service.
More from Climb Bio, Inc.
Regulatory Filings
2026
Jun 5
Regulatory Filings
2026
May 29
Interim / Quarterly Report
2026
May 7
Earnings Release
2026
May 7
Regulatory Filings
2026
May 5
Capital/Financing Update
2026
Apr 28
Board/Management Information
2026
Apr 3
Director's Dealing
2026
Feb 27
Major Shareholding Notification
2026
Feb 17
Director's Dealing
2026
Feb 17